1. References on natural products and biologically active compounds containing the 2-pyridazinone core. For reviews, see: (a). Singh, J.; Kumar, V.; Silakari, P.; Kumar, S. J. Heterocycl. Chem, 2023, 60, 929–949; (b). Asif, M. Central European Journal of Experimental Biology, 2017, 5, 1–19; (c). Syngenta Crop Protection AG, Clemens L. J Heterocyclic Chem, 2013, 69, 1106–1114; (d). Akhtar, W.; Shaquiquzzaman, M.; Akhter, M.; Verma, G.; Khan, M. F. and Alam， M. M. Eur. J. Med. Chem, 2016, 123, 256–281; (e). Singh, J.; Sharma, D.and Bansal, R. Future Med Chem, 2016, 9, 95–127; (f). Dubey, S.and Bhosle, P. A. Med Chem Res, 2015, 24, 3579–3598; (g). Bansal, R.; and Thota, S. Med Chem Res, 2013, 22, 2539–2552; For selected examples, see: (h). Seham, M. H; Wael, N. H.; Samy, S.; Hussein, S. M.; Hamada, A., J. Hazard. Mater.2021, 402, 123787-123797; (i). Shi, Q.; Shi, Y. Chang, K.; Chen, J.; Zhao, Z.; Zhu, W.; Xu, Y.; Li, B. and Qian, X. RSC Adv., 2019, 9, 36204–36207; (j). Lichtenthaler, H. K and Kleudgen H. K., Z. Naturforsch., C, J. Biosci., 2014, 32, 263-240; (k). Asif, M.; Singh, A. and Siddiqui, A. A. Med Chem Res, 2012, 21, 3336–3346; (l). Abouzid, N. A.; Khalil, E.M.; Ahmed, H. A. A.; El-Latif, M. E.; Araby. E, Med. Chem. Res.,2009, 19, 629-642.; (m). Bansal, R.; Kumar, D.; Carron, R.; de la Calle, C, Eur. J. Med. Chem., 2009, 44, 4441-4447.; (n). Thota, S.; Bansal, R., Med. Chem. Res. 2009, 19, 808-816.; (o). Curran, V. W.; Ross, A. J., Med. Chem. 1974, 17, 273-281.; (p). Piaz, D. V.; Cianini, G.; Turco, G.; Giovannoni, P.; Mideli, M.; Pirisino, R.; Pereeti, M.J., J. Pharm. Sci. 1991, 80, 341-348.; (q). Abouzida, K. and Bekhitb, S. A. Bioorg. Med. Chem., 2008, 16, 5547–5556.
2. References on the utilities of compounds containing bicyclic pyridazinones fused with pyrimidone scaffolds. For reviews, see: (a). Buglak, A. A.; Kapitonova, M. A.; Vechtomova, Y. L.and Telegina, T. A. INT. J. Mol 2022, 23, 15222–15272; (b).Vineesha . M; Athulya. C. E; Neethu M, Arun K, Int. J. Pharm. Sci. Rev. Res 2022, 77, 28-33; For selected examples see: (c). Crocetti, L.; Floresta, G.; Nazir, S.; Vergelli, C.; Bhogal, A.; Biancalani, C.; Cesari, N.; Giovannoni M. P. and Cilibrizzi, A. J. Struct. Chem.2022, 33, 769–793; (d). Eissaa, S.; Alkhaldia, S.; Chinnappana, R.; Siddiqua, A.; Abduljabbar, M.; Rahman, A. M. A.; Dasoukib, M.; Zourob, M. talanta, 2020, 216, 120951–120957.
3. [4 + 2] Annulation Reaction of In Situ Generated Azoalkenes with Azlactones: Access to 4,5-Dihydropyridazin-3(2H)-Ones
4. Design, synthesis, and bioactivities of novel pyridazinone derivatives containing
2‐phenylthiazole
or oxazole skeletons
5. Recent Progress in the Chemistry of Pyridazinones for Functional Group Transformations